TORONTO, Nov. 23 /CNW/ - DELISTING REVIEW - Orbus Pharma Inc. (the "Company") - Further to TSX Bulletin No. 2009-1190 dated September 21, 2009, TSX has determined to delist the common shares (Symbol: ORB) of the Company at the close of market on December 18, 2009 for failure to meet the continued listing requirements of TSX.
About TMX Group
TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver. For more information about TMX Group, visit our website at www.tmx.com.
SOURCE Toronto Stock Exchange Reviews and Suspensions
For further information: For further information: Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, email@example.com